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Human histone demethylase KDM6B can catalyse
sequential oxidations†
Richard J. Hopkinson, *ab Gareth W. Langley, a Roman Belle, a
Louise J. Walport, a Kate Dunne,ac Martin Mu¨nzel,a Eidarus Salah,a
Akane Kawamura, ac Timothy D. W. Claridge a and Christopher J. Schofield *a
Jumonji domain-containing demethylases (JmjC-KDMs) catalyse
demethylation of Ne-methylated lysines on histones and play
important roles in gene regulation. We report selectivity studies
on KDM6B (JMJD3), a disease-relevant JmjC-KDM, using synthetic
lysine analogues. The results unexpectedly reveal that KDM6B
accepts multiple Ne-alkylated lysine analogues, forming alcohol,
aldehyde and carboxylic acid products.
The regulation of histone lysyl methylation plays important
roles in modulating gene expression and is linked to multiple
diseases including cancers and mental disorders.1 Jumonji
domain-containing protein 3 (KDM6B or JMJD3), a human
2-oxoglutarate (2OG), ferrous iron, and oxygen dependent histone
demethylase, removes methyl groups from methylated H3 lysine-
27 and is involved in regulating transcription including of genes
involved in the production of cytokines (Fig. 1a and b).2–4
In addition to its action on histones, KDM6B interacts with other
proteins such as the tumour suppressor p53,5 suggesting KDM6B
catalysis may be more promiscuous than presently perceived.
Since work with other JmjC-KDMs, and more generally 2OG
oxygenases, has revealed the potential for expanded selectivity,6–9
we undertook substrate profiling studies with KDM6B using
synthetic histone fragments incorporating modified lysine
analogues. The results reveal that isolated KDM6B accepts a
variety of alkylated lysines, resulting in de-alkylated, hydroxylated
and carboxylated products. Reactions with an all-carbon analogue
of Ne-trimethyl-lysine did not reveal reaction, implying a positively charged Ne-alkylamino group is important in KDM6B substrate
recognition.
Initially, we synthesised histone H3 peptide fragments
containing Ne-modified lysines and Nd-modified ornithines at
the lysine-27 position (15 residue peptides, sequence KQLAT-
KAARKSAPAT, where K corresponds to the analogue, Fig. 1c
and Fig. S1, S2, ESI†). All peptides were synthesised as
C-terminal amides. The fragment peptides were then incubated
with KDM6B, 2OG, ascorbate, and ferrous iron (one hour,
25 1C) followed by analysis of the reaction mixtures using
MALDI-MS. Clear mass shifts were observed with 5 of the 11
tested peptides, indicating KDM6B catalysed reactions (Fig. 2).
Fig. 1 Outline of N-demethylation catalysed by KDM6B. (a) Reaction
scheme of KDM6B catalysis. Oxidation of an N-methyl C–H bond by
KDM6B results in formation of an unstable hemiaminal, which fragments
to form formaldehyde. (b) View from a crystal structure of KDM6B
in complex with histone substrate (PDB ID: 4EZH).12 The methylated
lysine-27 residue (red) protrudes towards the catalytic iron(II) bound in
the active site (for crystallographic purposes, nickel was substituted for
iron). N-Oxalylglycine (green) is a structural analogue of 2-oxoglutarate.
(c) Structures of lysine analogues used in this study. Note: the Lys(Me2),
Lys(Me/Et), Lys(Et2), Lys(iPr) and Lys (Me/iPr) residues are likely protonated
under the assay conditions used.
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In the samples with the peptide incorporating Ne-diethyl-
lysine (Lys(Et2)), a mass shift of 56 Da was observed relative to
the starting peptide, implying removal of both ethyl groups
(Fig. 2a). A species with a mass 16 Da greater than the starting
material was also observed, implying hydroxylation on one of
the terminal methyl groups of the diethyl-lysine residue, since
hydroxylation at the methylene position leads to de-alkylation.
MS analyses on samples containing KDM6B and Ne-ethyl-Ne-
methyl-lysine (Lys(Me/Et)) peptide revealed species with masses
14 Da, 28 Da, and 42 Da lower than the starting material,
suggesting formation of both Ne-demethylated and Ne-de-
ethylated products (Fig. 2b). In addition, with the Lys(Me/Et)
peptide three other products were observed in the MS experi-
ments, with masses 14 Da, 16 Da and 30 Da heavier than the
starting material (Fig. 2b). Time-course studies using MALDI-
MS analysis indicated that the Lys(Me/Et) peptide reacts rapidly
in the presence of KDM6B, with the fully de-alkylated lysine
being the major product over all time points (Fig. 2f). The
‘singly’ demethylated or de-ethylated species were more pre-
dominant at early time points, suggesting further de-alkylation
of these species occurs to form the fully de-alkylated product.
The species with a mass 16 Da heavier than the starting
material was observed at all time-points at a constant level;
however, the species with masses 14 Da and 30 Da heavier than
the starting material increased in concentration during the
experiment. The +16 Da, +14 Da and +30 Da mass shifts likely
represent sequential oxidation of the methyl group, forming
alcohol, aldehyde and carboxylic acid products (as precedented
with some other 2OG oxygenases, including the ten-eleven
translocation (TET) oxygenases, which are involved in chromatin
regulation;9–11 such sequential oxidation has not been previously
reported for JmjC-KDMs, Scheme 1 and Scheme S1, ESI†).
Evidence for reaction was also observed in samples containing
the Ne-isopropyl-lysine (Lys(iPr)) peptide and KDM6B (Fig. 2c).
The predominant species observed after incubation possessed a
mass 42 Da lower than the starting material, indicating removal
of the isopropyl group. 1H NMR analyses revealed production of
acetone (dH 2.2 ppm), implying KDM6B catalyses oxidation at the
sterically hindered tertiary isopropyl C–H bond (Fig. S3, ESI†).
As with the Lys(Me/Et) peptide (Fig. 2b) the MS analyses also
indicated the formation of products with masses 16 Da, 14 Da
and 30 Da heavier than the starting material (Fig. 2c and Fig. S4A,
ESI†). These species may be the product of hydroxylation of an
isopropyl methyl group, although their relatively low levels in the
mixtures precluded their detailed characterisation (note there is
potential for stereo-selective methyl group hydroxylation with the
Fig. 2 Analysis of KDM6B catalysed oxidations using mass spectrometry.
Mass spectra (MALDI) of incubations of KDM6B with (a) KQLATKAAR-
Lys(Et2)-SAPAT, (b) KQLATKAAR-Lys(Me/Et)-SAPAT, (c) KQLATKAAR-Lys(iPr)-
SAPAT, (d) KQLATKAAR-Lys(Me/iPr)-SAPAT, and (e) KQLATKAAR-Orn(Me/iPr)-
SAPAT. Mass spectra showing the unmodified peptides are overlaid (red).
(f) MS time-course for the incubation of KDM6B with KQLATKAAR-Lys(Me/Et)-
SAPAT over 30minutes. No evidence of KDM6B-catalysed oxidation of the other
substrate analogues given in Fig. 1 was observed.
Scheme 1 Summarised reactions of KDM6B with histone fragment
peptides containing (a) Lys(Et2), (b) Lys(Me/Et), (c) Lys(iPr), (d) Lys(Me/iPr),
and (e) Orn(Me/iPr), at position 27.
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isopropyl substrates). Two other peaks were also observed after
one hour that possessed masses lower than that of the unmodi-
fied peptide, suggesting fragmentation of at least one amino acid
side-chain (Fig. S5, ESI†). However, these species were not
observed in the time-course analyses (over 30 minutes) and were
too low-level for NMR characterisation.
MS analysis of samples with the Ne-isopropyl-Ne-methyl-
lysine (Lys(Me/iPr)) peptide analogue revealed production of
one major product with a mass 16 Da heavier than the starting
material (Fig. 2d and Fig. S4B, ESI†). 1H NMR analyses reaction
revealed low levels of product formation (note: under our NMR
conditions, KDM catalysis is lower than observed by MS,
possibly as a consequence of the non-catalytically optimised
ammonium formate buffer required for NMR and limited
oxygen availability in the NMR tube); while the product was
present at an insufficient level for full characterisation, com-
parison of the spectra with those with KDM4E (JMJD2E)6
suggested that the product resulted from reaction on an
isopropyl methyl group, resulting in a stable alcohol product
(as observed with KDM4E, Fig. S6, ESI†).
No reaction was observed between KDM6B and the Nd-diethyl-
ornithine (Orn(Et2)) peptide. However, a +16 Da mass shift was
observed in samples containing KDM6B and the Nd-isopropyl-Nd-
methyl-ornithine (Orn(Me/iPr)) peptide (Fig. 2d and Fig. S4C,
ESI†). The product of the reaction was tentatively assigned as the
Orn(Me/iPr) residue hydroxylated on an isopropyl methyl group,
as observed for the Lys(Me/iPr) residue.
Studies were then carried out on the peptide containing the
all-carbon analogue (Lys(C)),7 Incubation of the Lys(C) peptide
with KDM6B at either 25 1C, 37 1C, or with stoichiometric levels
of KDM6B did not reveal reaction by MS analysis. Further,
1H NMR analyses did not indicate reaction or stimulation of
2-oxoglutarate turnover, which can be observed when demeth-
ylases are incubated with substrate analogues.6,7,10 Further, no
reaction was observed in samples containing KDM6B and
either Ne-formyl- (Lys(For)), Ne-acetyl- (Lys(Ac)) or Ne-crotonyl-
lysine (Lys(Cr)) peptides, implying that the positive charge of
the side chain amine is important for KDM6B binding/activity
(note: no reaction of these residues was observed with either
KDM4E or PHF8).6,7 The lack of oxidation of Lys(For) is inter-
esting given that Lys(Me/Et) and Lys(Me/iPr) residues are
likely oxidised to the aldehyde and carboxylic acid derivatives
(Scheme 1).
We then profiled the relative activities of the peptides.
All analogue-containing substrate peptides (Lys(Et2), Lys(Me/Et),
Lys(iPr), Lys(Me/iPr) and Orn(Me/iPr) peptides) were poorer sub-
strates than the control (Lys(Me2)) peptide, as determined from
their relative turnover after one hour (Fig. 2) and time-course
studies (Fig. 2f and Fig. S3, S4, S6, ESI† note: the Lys(Et2) peptide
was too poor a substrate for time-course analysis). The most
efficient substrate analogue is the Lys(Me/Et) peptide, followed
by the peptides containing Lys(Me/iPr), Lys(iPr), Orn(Me/iPr)
and Lys(Et2), respectively. The relatively poor activity of the
peptides precluded accurate kinetic studies; however, their
reduced activity was evidenced by MS competition experiments
using a 21-mer Lys(Me3) peptide. The results revealed no inhibition
of KDM6B-catalysed Lys(Me3) demethylation on addition of ana-
logue peptides, within limits of detection, even with a 10-fold excess
of the substrate analogue (Fig. S7, ESI†). Further, no evidence for
oxidation of the analogue peptides was observed in the same
experiments, suggesting the presence of the Lys(Me3) peptide is
sufficient to out-compete these analogue peptides at the KDM6B
active site. No inhibition of KDM6B-catalysed Lys(Me3) demethyla-
tion was observed upon co-incubation with either the Lys(C),
Lys(For), Lys(Ac) or Lys(Cr) peptides (10-fold excess), suggesting
they are poor KDM6B binders (Fig. S8, ESI†).
Overall, the results using lysine analogues reveal that
KDM6B is capable of accepting multiple modified lysine ana-
logues as substrates and can facilitate oxidation at different
positions depending on the structure of the analogue. The
observation of hydroxylated products further supports the
proposed demethylation mechanism of the 2OG-dependent
JmjC demethylases, which is thought to proceed via initial
N-methyl group hydroxylation.6–9 Our evidence for multiple
oxidation events, potentially leading to carboxylated products,
supports a close mechanistic relationship between KDM6B and
the ferrous iron- and 2OG-dependent TET enzymes (which
come from a different structural 2OG oxygenase subfamily
compared to the JmjC-KDMs), which sequentially oxidise
5-methyl-cytosine on the 5-methyl group to hydroxymethyl,
aldehyde and carboxyl forms in DNA.11–14 The results also
suggest that it may be possible to engineer JmjC-KDM variants
that efficiently catalyse reactions other than Ne-methyl group
demethylation, a property that might be useful in dissecting the
precise biological roles of these complex multi-domain
enzymes. Overall, the available evidence is that the reactivity
of KDM6B appears most similar to that of KDM4E, consistent
with their structural active site similarity (as revealed by
crystallography).15,16 However, the observed de-ethylation
activity of Lys(Et2), and the possibility of multiple oxidation
reactions occurring on one carbon, reveals that KDM6B can
accept bulkier residues into its active site than does KDM4E.6
The lack of reaction with the all-carbon analogue of
Ne-trimethyl-lysine implies the importance of the side chain
amine for reactivity, an observation that may be useful for the
design of peptide-mimetic inhibitors.
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